Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.
about
AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients.What is better/reliable, mitosis counting or Ki67/MIB1 staining?Prognostic and predictive biomarkers post curative intent therapy.BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis.MTBP promotes migration and invasion by regulation of ZEB2-mediated epithelial-mesenchymal transition in lung cancer cells
P2860
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell cycle progression score i ...... d stage I lung adenocarcinoma.
@en
Cell cycle progression score i ...... d stage I lung adenocarcinoma.
@nl
type
label
Cell cycle progression score i ...... d stage I lung adenocarcinoma.
@en
Cell cycle progression score i ...... d stage I lung adenocarcinoma.
@nl
prefLabel
Cell cycle progression score i ...... d stage I lung adenocarcinoma.
@en
Cell cycle progression score i ...... d stage I lung adenocarcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Cell cycle progression score i ...... d stage I lung adenocarcinoma.
@en
P2093
Anne-Renee Hartman
Brent Evans
David R Jones
Jamie Chaft
Joe Dycoco
Joshua T Jones
Kathryn Kolquist
Kay See Tan
Kraig Yager
P2860
P304
35241-35256
P356
10.18632/ONCOTARGET.9129
P407
P577
2016-05-02T00:00:00Z